M. C. Ábalos-Aguilera

发表

Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation

N. Barbarroja, E. Collantes-Estévez, C. López-Pedrera, 2021, Arteriosclerosis, thrombosis, and vascular biology.

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs

F. Tinahones, M. Murri, N. Barbarroja, 2021, Frontiers in Immunology.

Association between Carotid Intima-Media Thickness and the Use of Biological or Small Molecule Therapies in Patients with Rheumatoid Arthritis

M. Rojas-Giménez, E. Collantes-Estévez, M. Á. Puche-Larrubia, 2021, Diagnostics.

The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

N. Barbarroja, M. Malagón, I. Arias de la Rosa, 2022, Journal of internal medicine.

Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis

N. Barbarroja, Y. Jiménez-Gómez, I. Arias de la Rosa, 2020, Therapeutic advances in musculoskeletal disease.

Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis

N. Barbarroja, Y. Jiménez-Gómez, I. Arias de la Rosa, 2020, Therapeutic advances in chronic disease.

Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2017, Journal of autoimmunity.

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission

N. Barbarroja, M. Malagón, I. Arias de la Rosa, 2020, Pediatric Rheumatology.

Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial

N. Barbarroja, S. Sciascia, P. Ruiz-Limón, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses

N. Barbarroja, E. Collantes-Estévez, C. López-Pedrera, 2021 .

AB1408-HPR INFLUENCE OF WEIGHT AND LIPID PROFILE IN RHEUMATIC PATIENTS WHO CHANGE FROM BIOLOGICAL THERAPY

M. C. Ábalos-Aguilera, L. Jurado, C. Gil, 2019, HPR Patients perspectives, functioning and health (descriptive: qualitative or quantitative).

Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2018, Human molecular genetics.

Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2021, Diagnostics.

Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis

N. Barbarroja, N. Mena-Vázquez, C. Romero-Barco, 2021, Frontiers in Immunology.

Achilles enthesitis on physical examination leads to worse outcomes after 2 years of follow up in patients with ankylosing spondylitis from REGISPONSER-AS registry

E. Collantes-Estévez, L. Ladehesa-Pineda, M. Á. Puche-Larrubia, 2023, Arthritis Research & Therapy.

Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness

N. Barbarroja, P. Ruiz-Limón, J. González-Reyes, 2020, Journal of Biomedical Science.

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy

Antonio González, N. Barbarroja, R. Luque, 2021, Annals of the Rheumatic Diseases.

Subclinical Atherosclerosis Measure by Carotid Ultrasound and Inflammatory Activity in Patients with Rheumatoid Arthritis and Spondylarthritis

M. Rojas-Giménez, E. Collantes-Estévez, M. Á. Puche-Larrubia, 2022, Journal of clinical medicine.

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome

Eduardo Collantes-Estévez, Nuria Barbarroja, Savino Sciascia, 2018, Haematologica.

Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues

N. Barbarroja, M. Malagón, A. Vidal-Puig, 2018, Journal of internal medicine.

Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness

N. Barbarroja, P. Ruiz-Limón, J. González-Reyes, 2020, Journal of Biomedical Science.

Prevalence and Associated Factors of Low Bone Mineral Density in the Femoral Neck and Total Hip in Axial Spondyloarthritis: Data from the CASTRO Cohort

J. L. Garrido-Castro, E. Collantes-Estévez, L. Ladehesa-Pineda, 2021, Journal of clinical medicine.

Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2020, Haematologica.

Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis

N. Barbarroja, J. González-Reyes, M. I. Burón, 2023, Arthritis & rheumatology.

Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.

N. Barbarroja, P. Ruiz-Limón, J. González-Reyes, 2017, Journal of autoimmunity.

Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation

J. A. Ranea, I. Moreno-Indias, P. Ruiz-Limón, 2024, Frontiers in Endocrinology.

Unsupervised Integrated Transcriptomic Analyses Define Atherothrombotic Risk in Primary Antiphospholipid Syndrome.

N. Barbarroja, E. Collantes-Estévez, C. López-Pedrera, 2020, Arteriosclerosis, thrombosis, and vascular biology.